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ABSTRACT
The European Columbus and Japanese Kibo laboratories are now fully operational on the International Space Station
(ISS), bringing decades of international planning to fruition. NASA is now completing launch and activation of
major research facilities that will be housed in the Destiny U.S. Laboratory, Columbus, and Kibo. These facilities
include major physical sciences capabilities for combustion, fluid physics, and materials science, as well as
additional multipurpose and supporting infrastructure. Expansion of the laboratory space and expansion to a 6-
person crew (May 2009), is already leading to significant increases in research throughput even before assembly is
completed. International research on the ISS includes exchanges of results, sharing of facilities, collaboration on
experiments, and joint publication and communication of accomplishments. Significant and ongoing increases in
research activity on ISS have occurred over the past year. Although research results lag behind on-orbit operations
by 2-5 years, the surge of early research activities following Space Shuttle return to flight in 2005 is now producing
an accompanying surge in scientific publications. Evidence of scientific productivity from early utilization
opportunities combined with the current pace of research activity in orbit are both important parts of the evidence
base for evaluating the potential future achievements of a complete and active ISS.
Historical Perspective
The International Space Station (ISS) has had a
continuous presence in space for the last 11 years,
and has been undergoing assembly during this time
period. ISS represents the most complex and largest
vehicle ever occupied in orbit, with partnership
including the U.S. National Aeronautics and Space
Administration (NASA), Canadian Space Agency
(CSA), European Space Agency (ESA), Roscosmos
(Russian Space Agency), and Japanese Aerospace
Exploration Agency (JAXA). Its importance for
human space exploration includes testing of new
technologies, systems operational tests, experience
gained from long term space flight operations, and
knowledge gained from scientific investigations in a
microgravity environment. ISS science and
technology facilities designed to accommodate a
broad range of scientific experiments, from cell
biology to human physiology, to materials and
physical science studies, tests of technologies and
systems support for human exploration will be
completed on ISS during its final year of assembly.
In 2008 the addition of ESA’s Columbus and JAXA’s
Kibo scientific modules to the US Destiny and
Russian segment modules tripled the ISS laboratory
space and research facilities, bringing decades of
international planning to fruition. A total of 24
facilities will be on ISS at assembly complete. From
September 2000 through April 2009 (Expedition 18),
over 400 investigations have been conducted on the
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ISS across all nations, representing over 600
scientists worldwide.
Timetable for ISS Research Results
We have identified roughly 200 publications through
2008 directly resulting from early NASA research on
the ISS. These publications can be found online at
www.nasa.gov/iss-science, and in NASA’s recent
Technical Publication detailing all USOS ISS
research through Expedition 15 [1]. The time
required to begin to see the results of these
investigations varies depending on the field of
research. For example, early ISS research results
indicate that although human research investigations
take longer to complete, the time to publication
following completion is relatively short (less than 1
year) [2]. Investigations in human research must be
carried out with a sufficient number of crewmembers
to achieve adequate statistical power in order to draw
appropriate conclusions. However, with the increase
of crew size to six in May 2009, a complement of up
to 20 human research investigations per expedition is
being manifested, which will significantly shorten the
time needed to complete human studies.
Physical and biological investigations have a
relatively short average completion time (less than 1
year), but may take longer to publish results. This
may be due to the number of analyses and models to
be completed following return of samples to Earth.
Technology development investigations on average
take a little more than a year to complete, but can
provide publications in less than a year. Likely, this is
due to the fact that the design of most of the
investigations in this category allows for downlink of
data from the ISS with simultaneous data analysis
[2].
Throughout the ISS construction period a program of
“early utilization” allowed research investigations to
take advantage of the facilities or crew already
onboard. Examples of early ISS research that has led
to benefits to Earth as well as the knowledge gained
from ISS experiments should enable future space
exploration in preparation for exploring the moon,
Mars, and beyond. Here we summarize a few key,
early research findings from life and physical science
across partners, as well as what is planned for the
future as the on-orbit labs are completed in 2010.
LIFE SCIENCE RESULTS TO WATCH
Biotechnology
An innovative biotechnology investigation that was
performed on ISS in 2002 involved a novel method
for encapsulation of several different anti-cancer
drugs, magnetic triggering particles, and
encapsulation of genetically engineered DNA
(Microencapsulation Electrostatic Processing
System, Principal investigator: D. Morrison, 2002).
The experiment system improved on existing
microencapsulation technology by using microgravity
to modify the fluid mechanics, interfacial behavior,
and biological processing methods compared to the
way the microcapsules would be formed in gravity
(Figure 1) [3, 4]. This ISS research has provided new
insight into the best formulations and conditions
required to produce microcapsules of different drugs,
particularly special capsules containing diagnostic
imaging materials and triggered release particles.
Additionally, this research has led to the development
of a ground-based technology to produce these
microcapsules on Earth [5]. Subsequent ground-
based studies have used this improved microcapsule
technology combined with ultrasound-guided
cryosurgery to deliver anti-tumor drugs directly to
human prostate tumors that were implanted into
mice, and this “focal approach” resulted in a dramatic
inhibition of tumor growth [4]. Clinical trials to
directly inject microcapsules of anti-tumor drugs into
tumor sites are planned at MD Anderson Cancer
Center in Houston and the Mayo Cancer Center in
Scottsdale, AZ.
Figure 1. Micro-balloons containing anti-tumor drugs
and small amounts of radio-contrast oil during MEPS
operations, 2002. Micrograph courtesy of D.
Morrison.
Another life sciences experiment performed on ISS
has yielded results that are contributing to
advancements in medical technology. The JAXA
and Roscosmos-sponsored investigation JAXA-GCF
(Japan Aerospace and Exploration Agency -
Granada Crystallization Facility High Quality
Protein Crystallization Project. Principal
investigator: H. Tanaka, 2002) was a unique
collaboration between several ISS International
Partners. The human hematopoietic prostaglandin D 2
synthase inhibitor protein (HQL-79) is a candidate
treatment in inhibiting the effects of Duchenne’s
muscular dystrophy. Investigators used the
microgravity environment of the ISS to grow larger
crystals and more accurately determine the 3-
dimensional structures of HQL-79 protein crystals
(Figure 2). The findings led to the development of a
more potent form of the protein, which is important
for the development of a novel treatment for
Duchenne’s muscular dystrophy [6. Russian
investigators have collaborated internationally to
grow macromolecular crystals on ISS since 2001,
including genetically engineered human insulin
(deposited into protein data bank in 2008),
tuberculosis, and cholera-derived pyrophosphatase.
The next generation of Russian-Japanese
collaboration in this area is the JAXA High Quality
Protein Crystal Growth experiment installed in Kibo
in August 2009.
Figure 2. A three-dimensional structure of HQL-79
derived from a crystal grown in space reveals an
associated water molecule embedded within the
crystal geometry. Understanding this improved
structure will aid in the development of next-
generation medical therapies (figure courtesy of
Yoshihiro Urade).
Microbial Virulence and Growth
A human presence in space is inevitably
accompanied by the presence of microbes. The extent
of changes to microorganisms in response to space
flight conditions is not completely understood;
however, previous studies have shown that
spaceflight causes a dysregulation in the immune
system [7, 8, 9]. As astronauts and cosmonauts live
for longer periods in a closed environment and use
recycled water and air, there is an increase in the
potential for negative impacts of microbial
contamination upon the health, safety, and
performance of crewmembers. Therefore,
understanding how the space environment affects
microorganisms and their disease-causing potential is
critically important for space flight missions and
requires further study [10, 11]. New knowledge on
microbial virulence gained in space has significant
potential for also benefitting life on Earth.
One of the most exciting microbial results reported
from ISS research is the confirmation that common
pathogens change and become more virulent during
space flight (Figure 3) [12]. The space environment
has been shown to induce key changes in microbial
cells that play a direct role in infectious disease,
including alterations of microbial growth rates,
antibiotic resistance, microbial invasion of host
tissue, organism virulence (the relative ability of a
microbe to cause disease), and genetic changes
within the microbe [12, 13]. The targets identified
from each of these microgravity-induced alterations
represent an opportunity to develop new and
improved therapeutics, including vaccines, as well as
biological and pharmaceutical agents aimed
specifically at treating the infection.
Figure 3. Astronaut John Phillips, STS-119 mission
specialist, activates the NLP-Vaccine experiment on
the middeck of a shuttle mission to ISS in March
2009. NASA image S 119-E-006156.
For example, Salmonella infection is one of the most
common forms of food poisoning in the US.
Worldwide, Salmonella diarrhea remains one of the
top three causes of infant mortality, so a vaccine has
the potential to make dramatic improvements in
health for developing countries [14]. Several lines
of research on Salmonella bacteria have been
conducted since 2006 on space shuttle missions
flown to the International Space Station. Collectively,
this body of work has shown that the virulence of this
organism increases in microgravity. One virulence
study performed in microgravity was the Microbe
experiment (Effect of Spaceflight on Microbial Gene
Expression and Virulence. Principal investigator: C.
Nickerson, 2006). Performed in September 2006, it
allowed investigators to examine changes in three
microbial pathogens: Salmonella typhimurium;
Pseudomonas aeruginosa; and, Candida albicans.
Initial data from Salmonella typhimurium (a leading
cause of human gastroenteritis), showed that 167
transcripts and 73 proteins were expressed differently
in flight when compared with ground controls [12].
This apparent response to the microgravity
environment included widespread alterations of gene
expression, particularly that of the RNA-regulatory
binding protein Hfq, that increased disease-causing
potential. When using a ground-based model of space
flight conditions on Earth, it was possible to
reproduce the Hfq regulation of some of the
Salmonella responses that were observed in flight.
Hfq is an RNA chaperone that binds to small
regulatory RNA and mRNA molecules to facilitate
mRNA translational regulation in a cell’s stress
response [12]. Hfq is also involved in promoting the
virulence of several pathogens [15]. Collectively, the
spaceflight data suggest that Hfq is involved in
globally regulating the S. typhimurium increased
virulence associated with spaceflight, and that
strategies to target Hfq and related protein regulators
could potentially decrease risk of infectious disease
on orbit and provide novel treatment therapies for
Salmonella infections on Earth.
The 2005 NASA Authorization Act designated a
portion of the ISS as a National Laboratory [16]. To
fulfill that mandate, NASA instituted the National
Lab Pathfinder (NLP) missions, which provide
opportunities for non-governmental entities to
conduct research and development on ISS by way of
each remaining space shuttle flight until the shuttle is
retired. In 2008, the NLP-Vaccine experiment,
sponsored by AstroGenetix, Inc., began research on
its first commercial product, a vaccine for
Salmonella, which yielded progressive results
targeting a potential vaccine over a succession of four
shuttle flights to ISS. The series of experiments used
bacterial knock-out gene targets to progressively
identify genes associated with microgravity-enhanced
bacterial virulence. The genes that have been
identified with this increased virulence have become
the basis for formulation of a new vaccine against
Salmonella typhimurium which is currently in the
planning stages for investigational review and
approval for future clinical trials.
The NLP-Vaccine bacterial virulence studies, which
initially focused on Salmonella, have since been
extended to methicillin-resistant Staphylococcus
aureus (MRSA) on space shuttle flights to the ISS
and during the Hubble Space Telescope Servicing
mission between March and May 2009. MRSA is a
type of bacteria that causes infections that are
resistant to the typical antibiotics used to treat illness
caused by this organism. According to the United
States Center for Disease Control, it is estimated that
MRSA is responsible for more than 94,000 serious
infections and 19,000 deaths annually [17].
Preliminary results from the STS-119 (March 2009)
experiment showed that growth in space induced
phenotypic changes in several microbes,
including MRSA, that were not observed in static
controls grown on the ground or in
rotating clinostats (Hammond and Becker, personal
communication). These results are highly valuable
for understanding mechanisms used by pathogens to
spread disease and also for designing ways to better
protect humans in space. With these new insights,
similar experiments will continue on the ISS with
related sets of pathogens which show promise for
potential new development of additional immune-
therapeutic products.
These are just two examples of the multiple scientific
teams and funding sources in the body of work on
microbial growth and virulence in space represents an
area of results to watch for in the future.
PHYSICAL SCIENCE RESULTS TO WATCH
Capillary Flow
The Capillary Flow Experiment (CFE) is a suite of
fluid physics experiments whose purpose is to
investigate capillary flows and phenomena in low
gravity (Capillary Flow Experiment, Principal
investigator: M. Weislogel, 2004-2008). The CFE
data that is to be obtained will be crucial to future
space exploration because they provide a foundation
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for physical models of fluids management in
microgravity, including fuel tanks and cryogen
storage systems (e.g., water recycling) and materials
processing in the liquid state. Under low-gravity
conditions, capillary forces can be exploited to
control fluid orientation so that such large mission-
critical systems perform predictably (Figure 4).
Figure 4. View of Capillary Flow Experiment (CFE)
in the U.S. Laboratory/Destiny, 2007. NASA image
ISS015E10587.
CFE used distinct experimental apparatus to study
three aspects of capillary flow: the contact line,
interior corner flow, and vane gap. The contact line
(the boundary between the liquid and the solid
surface of the container) controls the interface shape,
stability, and dynamics of capillary systems in low
gravity. Interior corner flow is aimed at practical
applications for fluid movement. Interior corners are
used in the design of fuel tanks so that the fuel will
always flow to the outlet of the tank in the absence of
gravity. Experimental results will guide the analysis
by providing the necessary boundary conditions as a
function of container cross section and fill fraction.
The benchmarked theory can then be used to improve
propellant management aboard spacecraft. The vane
gap focuses on capillary flow when there is a gap
between interior corners, such as in the gap formed
by an interior vane and tank wall of a large propellant
storage tank or the near intersection of vanes in a
tank with complex vane network.
CFE tests were operated during ISS Expeditions 9
through 16 (August 2004 – December 2007). Results
of the capillary flow investigations are still being
published. The contact line measurements have
shown the value of the apparatus as a benchmark for
computational fluid dynamics models [18]. The
numerical approaches used to predict behavior of
fluids in microgravity can be improved by evaluating
their boundary conditions determined by fluid
wetting container geometries. The results have
important implications for design of fuel tanks and
other fluid systems for use in orbit [19, 20, 21, 22,
23].
Materials Testing and Technology Development
One of the most prolific series of investigations on
the ISS was also the first externally-mounted
experiment on ISS, the Materials International Space
Station Experiment (MISSE, Principal Investigators:
W. Kinard and R. Walters, 2001 - ongoing).
Researchers from the private and public sector
prepared a wide range of samples for MISSE-1 and -
2, which were test beds for more than 400 materials
and coatings samples, testing their survivability under
the corrosive effects of the space environment,
including micrometeorite and orbital debris (MMOD)
strikes; atomic oxygen (AO) attack; intense
ultraviolet radiation from the sun; and, extreme
temperature swings. Beginning with the MISSE-1
and MISSE-2 deployment on the ISS in 2001, and
subsequent MISSE-3, MISSE-4, MISSE-5, and
MISSE-6 investigations through September 2009, the
experiments have provided space-validated results for
ground-based experiments, such as the durability of
materials to withstand AO erosion [24]. Because AO
erosion is the primary weathering force on spacecraft
materials, and true space environmental conditions
are difficult to replicate on Earth, MISSE provides a
valuable test platform that enables methods for
correlating and extrapolating ground results. Each
MISSE investigation has yielded results that have
subsequently led to increasingly complex follow-on
MISEE investigations that allow testing of new
materials and new technologies.
Thousands of materials samples have been tested to
date through the MISSE series of experiments
(Figure 5). MISSE results have been used to
understand and calibrate how materials that are
already in use on spacecraft degrade in the space
environment (for example, polymers used for
insulation, and solar array materials) and predict the
durability of new materials (e.g., the solar cell
materials that are planned for the Commercial Orbital
Transportation System) [25]. The US Department of
Defense (DOD) sponsored a MISSE-5 experiment
that was designed to characterize the durability and
electrical output of 39 advanced solar cell samples
that could be used on future space exploration
vehicles. Understanding the performance of these
materials will promote the effort to develop future
space power systems that could be better protected
against degradation from the space environment [26,
27].
Figure 5. Astronaut Patrick G. Forrester, during the
second STS-105 extravehicular activity, prepares to
work with the Materials International Space Station
Experiment 1 and 2 (MISSE-1 and 2) in August
2001. NASA Image: STS 105-346-007
MISSE samples that are currently being tested on the
ISS include materials that are part of the design of the
new Orion vehicle [24]. In addition to several recent
and upcoming publications, MISSE investigators
have devised methods for measuring and predicting
AO erosion yields, and have assembled data that will
provide important reference for designers,
developers, and builders of future spacecraft and
instruments [24, 25].
Additional Earth-based benefits of the MISSE series
results include the use of AO to remove organic
content from surfaces for diverse applications. For
example, methods using AO techniques have been
developed to restore valuable artwork, and to remove
bacteria contaminants from surgical implants [28]. A
recent patent was awarded to etch the surface of the
optical fibers that are used for blood analyses to
increase the surface area and enable rapid assessment
of blood glucose levels [29]. The MISSE team has
also spearheaded innovative collaborations among
industry, academia, NASA, and the DOD. The
MISSE series on ISS continues later this year with
the arrival of MISSE-7A and 7B with a new batch of
experiments and materials aboard STS-129, targeted
for launch in November 2009.
FUTURE ISS UTILIZATION
Although constraints on up-mass to orbit and crew
availability on ISS have limited the scope of research
during the early utilization period, the science return
to date provides strong evidence for the high
potential of ISS science return after assembly is
complete. As this unprecedented international
orbiting research platform is rapidly approaching
completion, it will continue to be used to conduct
multidisciplinary research and technology
development for the benefit of humankind, but with a
much higher science throughput than during the early
utilization period. From a U.S. perspective, future
use of the International Space Station has been
expanded through the designation of the ISS US
segment as a National Lab by Congress in the NASA
Authorization Act of 2005 [16]. This opens up the
ISS for use by other government agencies and
commercial interests to perform scientific and
engineering studies that further their objectives. The
ISS has and will continue to be a model for
international cooperation and collaboration in space.
The world’s space agencies share common goals for
ISS utilization. While the various international
partners may emphasize different aspects of research
to achieve their goals in the use of ISS, they are
unified in several important overarching goals. All
partners recognize the importance of leveraging the
ISS as an education platform to encourage and
motivate today’s youth to pursue careers in math,
science, and engineering. The ISS partners also share
the goal of advancing knowledge in the areas of
human physiology, biology, material and physical
sciences, and translating that knowledge to health,
socioeconomic, and environmental benefits on Earth.
We may not yet know what will be the most
important knowledge gained from the ISS, but we do
know that there are some amazing discoveries on the
way. Experiments such as those identified in this
paper are just a few success stories to watch expand
from the unique international laboratory that is the
International Space Station.
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